Probing Host‐Guest Inclusion Complex of DHP with β‐CD in Augmenting Bioavailability to Boost Biochemical Applications Optimized by Physicochemical and Molecular Docking

Ayesha Hossain,Pranish Bomzan,Priyanka Roy,Ajit Tudu,Modhusudan Mondal,Niloy Roy,Anindita Poddar,Salman Haydar,Sangita Dey,Anoop Kumar,Mahendra Nath Roy

DOI: https://doi.org/10.1002/slct.202402497

2024-10-30

ChemistrySelect

Abstract:2, 4‐Diamino‐6‐hydroxypyrimidine (DHP) is a chemical compound with significant relevance in various fields of science and medicine with distinctive chemical properties have extensive applications in pharmaceuticals, coordination chemistry, and the synthesis of bioactive compounds. In medicinal chemistry the production of NO from t_‐arginine and molecular oxygen in cytokine‐activated cells. But low bioavailability of the former one makes a boundary to boost its applications. The goal of the present research has to found the way to manipulate the bioavailability of the biologically significant DHP molecule. Here we explore the Molecular encapsulation is a significant tactic to enhance the bioavailability of some medications while maintaining their therapeutic effect with Cyclodextrins (CDs). This research aims to develop the inclusion complex of 2, 4‐diamino‐6‐hydroxypyrimidine (DHP) with β‐cyclodextrin (β‐CD) using an inclusion process, and to investigate the effect of inclusion on the photo stability and bioactivity of DHP. The formation of DHP‐β‐CD inclusion complex has been examined by means of physicochemical as well as spectroscopic techniques (1H NMR, FT‐IR, PXRD and SEM) suggesting the successful inclusion of the DHP molecule into the β‐CD cavity. The 1 : 1 stoichiometry of the inclusion complex was validated through Job's plot. β‐CD displayed a fairly strong affinity (Ka =889.67 M−1) for DHP, indicating that the binding process is thermodynamically feasible. A molecular docking study speculated the most preferred orientation of DHP molecule within the binding pocket of β‐CD cavity. The photostability of DHP was found to improve on complexation with β‐CD. In vitro antibacterial activity test demonstrated that the DHP‐β‐CD inclusion complex displayed better activity than pure DHP. DHP‐β‐CD inclusion complex (IC50 =240.04 μM) also exhibited relatively significant in vitro cytotoxic activity than pure DHP towards the human kidney cancer cell line (ACHN). These results reveals that the inclusion of DHP using β‐CD could lead to stabilization of DHP and efficient display of its bioactivity.

chemistry, multidisciplinary